Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

The Pennant Group Appoints Suzanne Snapper as Director

By: Pennant Group, Inc. via GlobeNewswire

May 16, 2025 at 12:12 PM EDT

EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the Company’s annual shareholder meeting.

Ms. Snapper is the Chief Financial Officer of the Ensign Group, Inc. (“Ensign”) (NASDAQ: ENSG), a leading publicly-traded provider of skilled nursing services. In this role, which Ms. Snapper has held since 2009, Ms. Snapper is responsible for Ensign’s accounting, finance, information technology, tax, internal controls, investor relations, managed care, treasury and finance risk management functions. Ms. Snapper has served as a member of Ensign’s board of directors since 2022. Prior to Ensign, Ms. Snapper acquired additional invaluable experience in financial management and reporting while employed at KPMG from 1996 to 2007. Ms. Snapper is a certified public accountant.

“Suzanne is a highly skilled and experienced health care leader who will add tremendous value to our organization,” said Brent Guerisoli, Pennant’s Chief Executive Officer and Chairman. “I am excited to have the benefit of her insights on our Board. Suzanne brings cutting edge expertise in financial matters, investor relations, and more. In addition, she deeply understands the culture and operating model that Pennant shares with Ensign. She is someone I trust and admire, and I look forward to working more closely with her.”

Ms. Snapper succeeds JoAnne Stringfield, who served on Pennant’s board from 2019 to 2025. Ms. Stringfield resigned at the end of her term to pursue other interests and to facilitate Ms. Snapper’s appointment.

“We are so grateful to JoAnne for the support she has given to Pennant as a founding member of its board of directors,” said Mr. Guerisoli. “JoAnne has been a dedicated and committed director whose contributions to the Company have been significant. We thank her for her service and wish her the best in her future endeavors.”

Ms. Snapper’s appointment is effective today, May 16, 2025. She will serve as a Class III director eligible for reelection in 2028. The number of directors on Pennant’s board will remain unchanged at eight.

About Pennant^:

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 137 home health and hospice agencies and 60 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.

Contact Information

The Pennant Group, Inc.
(208) 506-6100
ir@pennantgroup.com

SOURCE: The Pennant Group, Inc.